Latest Breaking News On - Nucleome therapeutics - Page 1 : comparemela.com

Advanced autoclave technology supports pioneering genetic research at Oxford Science Park

Nucleome Therapeutics, a leading UK biotech firm that specialises in decoding the dark genome's non-coding DNA regions to develop precision medicines for autoimmune diseases like multiple sclerosis, lupus, and rheumatoid arthritis, purchase LTE research-grade autoclave to assist with research. Click to read more.

United kingdomAnthony campbell carrPaul brackstoneOxford university bioescalatorOxford science enterprisesNucleome therapeuticsOxford universityPfizer venturesOld road campusOxford science parkSchrodinger building

Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts

Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Rockefeller universityNew yorkUnited statesBaden wübergUnited kingdomUniversity of pennsylvaniaCity ofUseh jack bissettSonia quaratinoPureos bioventuresBristol myers squibbIain kiltyJohn davisGerda blobelRussell greigJim hughes

Woodcock set to retire from FDA in early 2024—Chutes & Ladders

Woodcock set to retire from FDA in early 2024—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

United statesJeremy caldwellGabrielle massonGraham owensCarole huntsmanEric perakslisNoema pharmaMano iyerMax bayerLisa shamonRamon felcianoRobert califfMichael kauffmanThomas heathmanAeglea biotherapeuticsWilliam shakespeare

Nucleome Therapeutics appoints Dr Stephen Harrison as Chief Scientific Officer

Nucleome Therapeutics appoints Dr Stephen Harrison as Chief Scientific Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomDanuta jeziorskaStephen harrisonUniversity of california at berkeleyUniversity of cambridgeThios pharmaceuticalsUniversity of oxfordResearch biology at nektar therapeuticsChiron corporationNatural sciencesChief scientificChief scientific officerNucleome therapeuticsSan francisco bayEngine biosciencesSenior vice president

Rome Therapeutics adds $72 million to Series B round to harness dark genome

The U.S. company Rome Therapeutics plans to use the proceeds of its $72 million Series B round to take an experimental autoimmune disease treatment through early clinical testing.

United kingdomEnara bioRosana kapellerBristol myers squibbBoehringer ingelheimSanofi venturesNucleome therapeuticsMarkets amp regulationsClinical developmentLinical evolutionSeriesb funding roundGene therapy